Open Science publishing for the Drug Repurposing Community

Billions of dollars are wasted each year on non-reproducible biomedical research. The EU-funded drug repurposing initiative REPO4EU has embraced Open Science both to revolutionize how we approach drug discovery and how we communicate the results. The goal is to increase the reproducibility, interoperability, and reliability of the scholarly literature to streamline discoverability which in turn supports bioinformatics approaches, in-silico drug discovery, and precision medicine. Drug Repurposing Central is more than an open access journal, it is an open science communication platform for the whole drug repurposing community covering outputs ranging from conference abstracts to preprints and full open access journals. Drug Repurposing Central is: <!-- named anchor --> Open: Creative Commons 4.0 Open access license Rapid: Preprints, Community run Diamond OA journal Interoperable: DOI, ORCID, Institutional ID ROR, FundRef ID, RRID Reproducible: Scientific rigor report prior to publication, NISO Data availability statements Inclusive: Open community review, lay summaries, user collections